Literature DB >> 11890335

Primary non-Hodgkin lymphoma of the right colon: a retrospective clinical-pathological study.

J Waisberg1, S H Bromberg, M I Franco, C O Matheus, A Zanotto, L F Petrolino, A M Beltrami, A C Godoy.   

Abstract

The objective of this study was to analyze the results of surgical treatment of primary non-Hodgkin lymphomas of the right colon. Ten patients were operated on with curative intention. Dawson's criteria were used to characterize the colonic lymphoma as a primary lymphomas. In the staging of the tumor, the Ann Arbor classification for gastrointestinal lymphomas modified by Musshoff and Schmidt-Vollmer was used. The histological classification was made by using the International Working Formulation Group system. All patients were submitted to radical right colectomy and 6 of them received postoperative chemotherapy. The overall average survival was 39.2 months. Four of the patients are still alive, without active disease, with an average survival of 85.2 months. Six patients died due to relapse in the abdomen, with an average survival of 8.2 months. These results suggest that it is advantageous to patient survival to have them submitted for resection of their lesions at an initial stage of the disease (IE and IIE1). Chemotherapy must be used as a complementary treatment in locally advanced lesions, in an attempt to control the residual microscopic disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11890335

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  4 in total

1.  Colonic lymphoma presenting acutely with perforated colo-splenic fistula.

Authors:  Ali Ahmed Al-Zahir; Abdul-Wahed Nasir Meshikhes
Journal:  Int J Surg Case Rep       Date:  2012-04-27

2.  Colorectal lymphoma.

Authors:  Melissa Times
Journal:  Clin Colon Rectal Surg       Date:  2011-09

3.  Primary lymphoma of the colon.

Authors:  Leo F Tauro; Harold W Furtado; Panambur S Aithala; Clement S D'Souza; Celine George; Santhrupth H Vishnumoorthy
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

4.  Chemotherapy-induced small bowel perforation in a patient with extrapulmonary small-cell carcinoma of the small bowel.

Authors:  S Owen; M Chasen
Journal:  Curr Oncol       Date:  2008-12       Impact factor: 3.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.